Form 4: Royalty Pharma Executive Sells Shares
Insider Transaction (Form 4)
Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc, sold 100,000 shares of common stock on August 18, 2026 for $59.97 per share.
Summary
- Open-market sale: disposed of 100,000 Class A Ordinary Shares at $59.97 ($5,997,250) on August 18, 2026; holds 370,401 after (Indirect).
- Bona fide gift: disposed of 16,800 Class A Ordinary Shares on August 19, 2026; holds 23,200 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,997,250 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Christopher Hite — Officer (EVP & Chairman, Partnering)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Class A Ordinary Shares | 100,000 | $60 | $6.0M | 370,401 |
| 2026-08-19 | Bona fide gift | Class A Ordinary Shares | 16,800 | — | — | 23,200 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (100,000 shares) |
| 2026-08-19 | Bona fide gift (16,800 shares) |
Keywords
insider transaction, Form 4, RPRX, Royalty Pharma plc, bearish, Christopher Hite
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.